Real-time enrollment status for this locally advanced unresectable pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:14 PM UTC
| NCT Number | NCT05919238 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Unresectable Pancreatic Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Impact Biotech Ltd |
| Last Updated on CT.gov | February 12, 2026 (Feb 12, 2026) |
As of July 13, 2026: Clinical trial NCT05919238 is currently recruiting participants. This clinical trial study for locally advanced unresectable pancreatic adenocarcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Impact Biotech Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05919238 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05919238 was last updated Feb 12, 2026 (February 12, 2026). HelloStudys verifies this status automatically.